The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Closed Drug Transfer Systems Market Research Report 2024
Synopsis
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
The global Closed Drug Transfer Systems market was valued at US$ 797.1 million in 2023 and is anticipated to reach US$ 2829 million by 2030, witnessing a CAGR of 19.6% during the forecast period 2024-2030.
North America is the largest Closed Drug Transfer Systems market with about 73% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical etc. Top 3 companies occupied about 74% market share.
This report aims to provide a comprehensive presentation of the global market for Closed Drug Transfer Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Closed Drug Transfer Systems.
Report Scope
The Closed Drug Transfer Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Closed Drug Transfer Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Closed Drug Transfer Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD Medical, Inc
Equashield, LLC
ICU Medical, Inc
Teva Medical Ltd
Corvida Medical
Segment by Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Closed Drug Transfer Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
The global Closed Drug Transfer Systems market was valued at US$ 797.1 million in 2023 and is anticipated to reach US$ 2829 million by 2030, witnessing a CAGR of 19.6% during the forecast period 2024-2030.
North America is the largest Closed Drug Transfer Systems market with about 73% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical etc. Top 3 companies occupied about 74% market share.
This report aims to provide a comprehensive presentation of the global market for Closed Drug Transfer Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Closed Drug Transfer Systems.
Report Scope
The Closed Drug Transfer Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Closed Drug Transfer Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Closed Drug Transfer Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD Medical, Inc
Equashield, LLC
ICU Medical, Inc
Teva Medical Ltd
Corvida Medical
Segment by Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Closed Drug Transfer Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Closed Drug Transfer Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Closed Vial Access Devices
1.2.3 Closed Syringe Safety Devices
1.2.4 Closed Bag/Line Access Devices
1.3 Market by Application
1.3.1 Global Closed Drug Transfer Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Closed Drug Transfer Systems Market Perspective (2019-2030)
2.2 Closed Drug Transfer Systems Growth Trends by Region
2.2.1 Global Closed Drug Transfer Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Closed Drug Transfer Systems Historic Market Size by Region (2019-2024)
2.2.3 Closed Drug Transfer Systems Forecasted Market Size by Region (2025-2030)
2.3 Closed Drug Transfer Systems Market Dynamics
2.3.1 Closed Drug Transfer Systems Industry Trends
2.3.2 Closed Drug Transfer Systems Market Drivers
2.3.3 Closed Drug Transfer Systems Market Challenges
2.3.4 Closed Drug Transfer Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Closed Drug Transfer Systems Players by Revenue
3.1.1 Global Top Closed Drug Transfer Systems Players by Revenue (2019-2024)
3.1.2 Global Closed Drug Transfer Systems Revenue Market Share by Players (2019-2024)
3.2 Global Closed Drug Transfer Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Closed Drug Transfer Systems Revenue
3.4 Global Closed Drug Transfer Systems Market Concentration Ratio
3.4.1 Global Closed Drug Transfer Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Closed Drug Transfer Systems Revenue in 2023
3.5 Closed Drug Transfer Systems Key Players Head office and Area Served
3.6 Key Players Closed Drug Transfer Systems Product Solution and Service
3.7 Date of Enter into Closed Drug Transfer Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Closed Drug Transfer Systems Breakdown Data by Type
4.1 Global Closed Drug Transfer Systems Historic Market Size by Type (2019-2024)
4.2 Global Closed Drug Transfer Systems Forecasted Market Size by Type (2025-2030)
5 Closed Drug Transfer Systems Breakdown Data by Application
5.1 Global Closed Drug Transfer Systems Historic Market Size by Application (2019-2024)
5.2 Global Closed Drug Transfer Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Closed Drug Transfer Systems Market Size (2019-2030)
6.2 North America Closed Drug Transfer Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Closed Drug Transfer Systems Market Size by Country (2019-2024)
6.4 North America Closed Drug Transfer Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Closed Drug Transfer Systems Market Size (2019-2030)
7.2 Europe Closed Drug Transfer Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Closed Drug Transfer Systems Market Size by Country (2019-2024)
7.4 Europe Closed Drug Transfer Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Closed Drug Transfer Systems Market Size (2019-2030)
8.2 Asia-Pacific Closed Drug Transfer Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Closed Drug Transfer Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Closed Drug Transfer Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Closed Drug Transfer Systems Market Size (2019-2030)
9.2 Latin America Closed Drug Transfer Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Closed Drug Transfer Systems Market Size by Country (2019-2024)
9.4 Latin America Closed Drug Transfer Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Closed Drug Transfer Systems Market Size (2019-2030)
10.2 Middle East & Africa Closed Drug Transfer Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Closed Drug Transfer Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Closed Drug Transfer Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD Medical, Inc
11.1.1 BD Medical, Inc Company Detail
11.1.2 BD Medical, Inc Business Overview
11.1.3 BD Medical, Inc Closed Drug Transfer Systems Introduction
11.1.4 BD Medical, Inc Revenue in Closed Drug Transfer Systems Business (2019-2024)
11.1.5 BD Medical, Inc Recent Development
11.2 Equashield, LLC
11.2.1 Equashield, LLC Company Detail
11.2.2 Equashield, LLC Business Overview
11.2.3 Equashield, LLC Closed Drug Transfer Systems Introduction
11.2.4 Equashield, LLC Revenue in Closed Drug Transfer Systems Business (2019-2024)
11.2.5 Equashield, LLC Recent Development
11.3 ICU Medical, Inc
11.3.1 ICU Medical, Inc Company Detail
11.3.2 ICU Medical, Inc Business Overview
11.3.3 ICU Medical, Inc Closed Drug Transfer Systems Introduction
11.3.4 ICU Medical, Inc Revenue in Closed Drug Transfer Systems Business (2019-2024)
11.3.5 ICU Medical, Inc Recent Development
11.4 Teva Medical Ltd
11.4.1 Teva Medical Ltd Company Detail
11.4.2 Teva Medical Ltd Business Overview
11.4.3 Teva Medical Ltd Closed Drug Transfer Systems Introduction
11.4.4 Teva Medical Ltd Revenue in Closed Drug Transfer Systems Business (2019-2024)
11.4.5 Teva Medical Ltd Recent Development
11.5 Corvida Medical
11.5.1 Corvida Medical Company Detail
11.5.2 Corvida Medical Business Overview
11.5.3 Corvida Medical Closed Drug Transfer Systems Introduction
11.5.4 Corvida Medical Revenue in Closed Drug Transfer Systems Business (2019-2024)
11.5.5 Corvida Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
